US Oncology to Provide Latest Company Update at JP Morgan Healthcare Conference
06 Enero 2004 - 7:01AM
PR Newswire (US)
US Oncology to Provide Latest Company Update at JP Morgan
Healthcare Conference HOUSTON, Jan. 6 /PRNewswire-FirstCall/ -- US
Oncology, Inc. will be one of the presenting companies at the 22nd
Annual JP Morgan Healthcare Conference to be held Jan. 12-15, 2004
at the Westin St. Francis Hotel in San Francisco. US Oncology Chief
Financial Officer Bruce Broussard will deliver a presentation
outlining the company's current operations and financial results,
its position in the cancer-care services industry and the impact of
recently passed Medicare reform legislation. The 30-minute
presentation on Wednesday, Jan. 13 at 11:30 a.m. (PST) will be
followed by a question-and-answer session. An electronic copy of
the presentation will be available on the Investor Relations
section of the US Oncology Web site at http://www.usoncology.com/
following Broussard's session. About US Oncology, Inc. US Oncology,
headquartered in Houston, Texas, is America's premier cancer- care
services company. The company provides comprehensive services to a
network of affiliated practices -- comprising more than 875
affiliated physicians in over 450 sites, including 78 integrated
cancer centers -- in 30 states, with the mission of expanding
access to and improving the quality of cancer care in local
communities. These practices care for approximately 15 percent of
the country's new cancer cases each year. DATASOURCE: US Oncology,
Inc. CONTACT: Steve Sievert of US Oncology, Inc., +1-832-601-6193,
or Web site: http://www.usoncology.com/
Copyright
US Oncology (NASDAQ:USON)
Gráfica de Acción Histórica
De Feb 2025 a Mar 2025
US Oncology (NASDAQ:USON)
Gráfica de Acción Histórica
De Mar 2024 a Mar 2025
Real-Time news about US Oncology (MM) (NASDAQ): 0 recent articles
Más de US Oncology (MM) Artículos de Noticias